TFX TELEFLEX INC

NYSE Surgical & Medical Instruments & Apparatus DE CIK: 0000096943
AI RATING
SELL
75% Confidence

Investment Thesis

Despite strong revenue growth of 17.2%, Teleflex is currently unprofitable with a net loss of $8.2M and critically weak interest coverage of 0.5x, indicating it cannot service its $2.5B debt from operating income. The 56.1% gross margin indicates healthy product economics, but operating expenses are severely constraining profitability, creating unsustainable financial distress.

Strengths

  • + Strong revenue growth of 17.2% YoY demonstrates market demand for products
  • + Healthy gross margin of 56.1% indicates pricing power and efficient production costs
  • + Strong liquidity position with current ratio of 2.55x and quick ratio of 2.03x provides near-term financial flexibility

Risks

  • ! Interest coverage of 0.5x is critically weak; operating income cannot cover interest expense, making debt unsustainable
  • ! Currently unprofitable with net loss of $8.2M and negative net margin of -1.5%, indicating fundamental operational problems
  • ! Operating margin of only 3.7% despite 56.1% gross margin reveals severe operating expense issues that are not being controlled
  • ! Long-term debt of $2.5B is substantial relative to current earnings capacity and creates leverage risk
  • ! Missing operating cash flow and free cash flow data prevents assessment of actual cash generation ability

Key Metrics to Watch

Financial Metrics

Revenue
548.3M
Net Income
-8.2M
EPS (Diluted)
$-0.18
Free Cash Flow
N/A
Total Assets
6.8B
Cash
309.4M

Profitability Ratios

Gross Margin 56.1%
Operating Margin 3.7%
Net Margin -1.5%
ROE -0.3%
ROA -0.1%
FCF Margin N/A

Balance Sheet & Liquidity

Current Ratio
2.55x
Quick Ratio
2.03x
Debt/Equity
0.82x
Debt/Assets
54.5%
Interest Coverage
0.46x
Long-term Debt
2.5B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-09T13:23:43.387404 | Data as of: 2026-03-31 | Powered by Claude AI